These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 214818)

  • 1. Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.
    Rubin B; Antonaccio MJ; Horovitz ZP
    Prog Cardiovasc Dis; 1978; 21(3):183-94. PubMed ID: 214818
    [No Abstract]   [Full Text] [Related]  

  • 2. SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
    Rubin B; Laffan RJ; Kotler DG; O'Keefe EH; Demaio DA; Goldberg ME
    J Pharmacol Exp Ther; 1978 Feb; 204(2):271-80. PubMed ID: 202692
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.
    Rubin B; Antonaccio MJ; Goldberg ME; Harris DN; Itkin AG; Horovitz ZP; Panasevich RE; Laffan RJ
    Eur J Pharmacol; 1978 Oct; 51(4):377-88. PubMed ID: 213296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute vasodepressor effect of D-3-mercapto-2-methylpropanoyl-L-proline (SQ 14,225) in the stroke-prone substrain of spontaneously hypertensive rats (SHRSP).
    Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1979 Feb; 29(1):133-5. PubMed ID: 222924
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme.
    Vaughan ED; Carey RM; Ayers CR; Peach MJ
    J Clin Endocrinol Metab; 1979 May; 48(5):869-71. PubMed ID: 219011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.
    Ondetti MA; Rubin B; Cushman DW
    Science; 1977 Apr; 196(4288):441-4. PubMed ID: 191908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor.
    Sakai K; Aono J; Shiraki Y; Hinohara Y; Akamatsu A; Tanaka S; Kuromaru K
    Tohoku J Exp Med; 1987 Aug; 152(4):363-74. PubMed ID: 3660405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
    Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
    Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of blood pressure responses to captopril, an orally active converting enzyme inhibitor, in rats with various forms of experimental hypertension (author's transl)].
    Mikami H; Ogihara T; Kanda T; Higaki J; Naka T; Maruyama A; Hata T; Iwanaga K; Kumahara Y
    Nihon Naibunpi Gakkai Zasshi; 1980 Feb; 56(2):180-96. PubMed ID: 6245943
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Seymour AA; Swerdel JN; Abboa-Offei B
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
    Jandhyala BS; Washington GF; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.
    Laffan RJ; Goldberg ME; High JP; Schaeffer TR; Waugh MH; Rubin B
    J Pharmacol Exp Ther; 1978 Feb; 204(2):281-8. PubMed ID: 202693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.
    Brunner HR; Waeber B; Wauters JP; Turin G; McKinstry D; Gavras H
    Lancet; 1978 Sep; 2(8092 Pt 1):704-7. PubMed ID: 80634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.